ArticleTrials2024

Personalized, interdisciplinary patient pathway for cross-sector care of multimorbid patients (eliPfad trial): study protocol for a randomized controlled trial.

Christoph Heinrich Lindemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.